NCT01426828View on ClinicalTrials.gov

Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2016

Study Completion Date

December 31, 2017

Conditions
Multiple Myeloma
Interventions
BIOLOGICAL

CD3/CD28

CD3/CD28 activated autologous lymphocytes intravenously

Trial Locations (2)

19104

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

77030

University of Texas, MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

University of Pennsylvania

OTHER

NCT01426828 - Id-KLH Vaccine + T Cells in Subjects With Myeloma Undergoing Transplant | Biotech Hunter | Biotech Hunter